Abiopharma

🔍 MAZELSKY JONATHAN JAY (Director)

Company: DENTSPLY SIRONA Inc. (XRAY)

Report Date: 2026-01-09

Detailed Transactions and Holdings:

• Acquired 395 shares of Common Stock (Direct)
  Date: 2026-01-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 28,846.53 | transaction_form_type: 4 | Footnotes: F1
• Acquired 154 shares of Phantom Stock (Directors' Deferred Compensation) DDC (Derivative)
  Date: 2026-01-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 14,535.21 | transaction_form_type: 4 | Footnotes: F2, F3, F2, F2

Footnotes:

• F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
• F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director.
• F3: Comprised of phantom stock acquired as a result of accrued dividends.